Evidence map›Paper›PMID 30128032›Full record

ArticleOncology letters2018

Concurrent palliative external radiotherapy with sorafenib or doxorubicin for bulky differentiated thyroid carcinoma: A case report.

Karen S Cortés-Mateus, Katarzyna Holub, Fabricio Racca, Juan José Grau, Jaume Capdevila

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Karen S Cortés-MateusMedical Oncology Department and Radiation Oncology Department, University of Barcelona, IDIBAPS, Hospital Clinic Barcelona, 08036 Barcelona, Spain.
Katarzyna HolubMedical Oncology Department and Radiation Oncology Department, University of Barcelona, IDIBAPS, Hospital Clinic Barcelona, 08036 Barcelona, Spain.
Fabricio RaccaVall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.
Juan José GrauMedical Oncology Department and Radiation Oncology Department, University of Barcelona, IDIBAPS, Hospital Clinic Barcelona, 08036 Barcelona, Spain.
Jaume CapdevilaVall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain.
Hospital Clínic de Barcelona · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Administration of external beam radiotherapy (EBRT) for a bulky recurrence or primary bulky tumor of differentiated thyroid carcinoma (DTC) is rare. No previous experience is available on the feasibility of administering EBRT simultaneously with systemic treatment with doxorubicin or sorafenib, or both. The present case study reported the results from two different institutions on 5 consecutive patients. Side effects and tolerance to radiotherapy plus systemic treatment with doxorubicin (20 mg/m

Indexed as

doxorubicinsorafenibthyroid cancertolerancetoxicity

Identifiers

PMID30128032
PMCPMC6096225
OpenAlexW2811005789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.